# NCT00929591 (NCT00929591)

> SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00929591
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: SWOG Cancer Research Network
- Conditions: Breast Cancer
- Interventions: cyclophosphamide; doxorubicin hydrochloride; endocrine therapy; endocrine-modulating drug therapy; fluorouracil; tamoxifen citrate; brachytherapy; low-LET electron therapy; low-LET photon therapy; radiation therapy
- Enrollment: 1558
- Primary outcome: Disease-free survival
- Primary outcome: Overall survival
- Primary outcome: Toxicity/morbidity of treatment

## Commentary we found

- YouTube: 5
- Podcasts: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct00929591

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00929591", "email": "<work email>"}; the inbox owner confirms by the emailed link.